FR2005599A1 - Composition pharmaceutique liquide anti-acide - Google Patents

Composition pharmaceutique liquide anti-acide

Info

Publication number
FR2005599A1
FR2005599A1 FR6909622A FR6909622A FR2005599A1 FR 2005599 A1 FR2005599 A1 FR 2005599A1 FR 6909622 A FR6909622 A FR 6909622A FR 6909622 A FR6909622 A FR 6909622A FR 2005599 A1 FR2005599 A1 FR 2005599A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
acid liquid
composition anti
acid
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6909622A
Other languages
English (en)
Other versions
FR2005599B1 (fr
Inventor
Mayron David
Jeffries Tiano Frank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2005599A1 publication Critical patent/FR2005599A1/fr
Application granted granted Critical
Publication of FR2005599B1 publication Critical patent/FR2005599B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6909622A 1968-04-05 1969-03-31 Composition pharmaceutique liquide anti-acide Granted FR2005599A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71923468A 1968-04-05 1968-04-05

Publications (2)

Publication Number Publication Date
FR2005599A1 true FR2005599A1 (fr) 1969-12-12
FR2005599B1 FR2005599B1 (fr) 1973-12-21

Family

ID=24889291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6909622A Granted FR2005599A1 (fr) 1968-04-05 1969-03-31 Composition pharmaceutique liquide anti-acide

Country Status (10)

Country Link
US (1) US3621094A (fr)
AU (1) AU443154B2 (fr)
BE (1) BE731060A (fr)
DE (1) DE1915798C3 (fr)
FR (1) FR2005599A1 (fr)
GB (1) GB1200157A (fr)
IE (1) IE33016B1 (fr)
IL (1) IL31858A (fr)
LU (1) LU58367A1 (fr)
NL (1) NL6905135A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1076479A (fr) * 1976-09-17 1980-04-29 Lewis/Howe Company Suspensions ou emulsions concentrees d'hydroxyde de magnesium, et methode de fabrication
JPS58192739U (ja) * 1982-06-19 1983-12-21 仁川 春夫 車両牽引レツカ−
DE8334745U1 (de) * 1983-12-03 1985-07-18 Schöberl, Franz, 8400 Regensburg Abschleppvorrichtung für Kraftfahrzeuge
US4548817A (en) * 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
WO1986005688A1 (fr) * 1985-03-27 1986-10-09 Baxter Travenol Laboratories, Inc. Unite d'addition d'un complement de calcium
EP0222834A4 (fr) * 1985-04-18 1989-10-04 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth.
NZ275690A (en) * 1993-10-13 1998-08-26 Warner Lambert Co Antacid composition comprising calcium carbonate and a second buffer compound which is calcium citrate and/or calcium phosphate
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
ES2658964T3 (es) * 2007-08-03 2018-03-13 Nucitec S.A. De C.V. Composiciones y métodos para el tratamiento y la prevención de la osteoartritis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062714A (en) * 1960-03-11 1962-11-06 Lewis Howe Company Antacid composition
US3215601A (en) * 1963-02-07 1965-11-02 Warner Lambert Pharmaceutical Antacid composition and method of making same
US3361769A (en) * 1964-01-22 1968-01-02 Synergistics Inc Bi-metallic salts of gluconic, glucuronic, or galacturonic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate

Also Published As

Publication number Publication date
AU443154B2 (en) 1973-11-28
NL6905135A (fr) 1969-10-07
US3621094A (en) 1971-11-16
DE1915798A1 (de) 1969-11-06
IE33016B1 (en) 1974-02-20
IL31858A (en) 1972-05-30
LU58367A1 (fr) 1970-11-09
IL31858A0 (en) 1969-05-28
IE33016L (en) 1969-10-05
DE1915798B2 (de) 1977-08-25
BE731060A (fr) 1969-10-06
DE1915798C3 (de) 1978-04-27
FR2005599B1 (fr) 1973-12-21
GB1200157A (en) 1970-07-29
AU5219669A (en) 1970-09-24

Similar Documents

Publication Publication Date Title
BE761441A (fr) Distributeur de liquide
FI56487B (fi) Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition
CH518541A (fr) Distributeur de liquide
AT313798B (de) Behälter
CH506976A (de) Einsäulentisch
BE768269A (fr) Composition pharmaceutique
AT269361B (de) Medikamentbehälter
BE770721A (fr) Composition microbicide liquide stable
CH536663A (de) Flüssigkeitsverteiler
FR2005599A1 (fr) Composition pharmaceutique liquide anti-acide
DK143912C (da) Doseringsapparat
BE749864A (fr) Nouvelle composition pharmaceutique effervescente
CH540831A (de) Behälter
CH483279A (de) Flüssigkeitszerstäuber
CH517630A (de) Flüssigkeitsbehälter
BE775640A (fr) Composition pharmaceutique
BE783014A (fr) Composition detergente liquide
CH525132A (de) Behälter
BE774464A (fr) Detergent liquide
AT307306B (de) Behälter
BE776768A (fr) Composition pharmaceutique
BE770399A (fr) Composition pharmaceutique
RO62476A (fr) Composition insecticide liquide volatile
BE762009A (fr) Defloculant pour peinture liquide
BE745022A (fr) Composition pharmaceutique

Legal Events

Date Code Title Description
ST Notification of lapse